By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


KaloBios Pharmaceuticals, Inc. 

260 East Grand Avenue

South San Francisco  California  94080  U.S.A.
Phone: 650-243-3100 Fax: 650-243-3260



Company News
KaloBios (KBIO) Releases Statement Regarding U.S. Trustee Motion 2/2/2016 2:20:41 PM
KaloBios (KBIO) Seeks Judicial Permission to Pay Out Bonuses in Effort to Shake Off Shadow of Martin Shkreli 2/1/2016 8:44:02 AM
KaloBios (KBIO) Withdraws Appeal On Nasdaq Delisting 1/13/2016 6:31:46 AM
KaloBios (KBIO) Announces Board Changes And New Appointments 1/11/2016 10:12:18 AM
The Deal Martin Shkreli was Trying to Complete for KaloBios (KBIO) Before He was Arrested 1/6/2016 6:42:44 AM
KaloBios (KBIO) Notified By Nasdaq Stock Market Of Additional Bases For Delisting 12/31/2015 9:36:22 AM
Martin Shkreli's Former Drugmaker KaloBios (KBIO) Files for Bankruptcy 12/30/2015 6:16:21 AM
KaloBios (KBIO) Announces Submission Of Request For Appeal Of Nasdaq Delisting 12/29/2015 10:53:38 AM
KaloBios (KBIO) Loses CFO, Board Members and Accounting Firm in Wake of Martin Shkreli Indictment 12/29/2015 6:41:38 AM
Nasdaq to Delist Martin Shkreli's Former Firm KaloBios (KBIO) 12/28/2015 6:46:11 AM